Product Information
ORPHENADRINE 60 MG/2 ML VIAL is a generic product labeled by Sagent Pharmaceuticals, priced at $5.7303 per ML under NDC 25021065102. Its NADAC has been published 94 times since Dec 18, 2024.
FDA first approved this application on Aug 30, 2011. Its Orange Book therapeutic-equivalence code is AP.
Strength
30 mg/mL
Manufacturer
Sagent PharmaceuticalsNDC
25021065102
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
ORPHENADRINE CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA090585FDA Approved
8/30/2011
TE Code
AP
On Market Since
10/1/2011
Pharmacological Classes
Price Statistics
The NADAC for ORPHENADRINE 60 MG/2 ML VIAL has been published 94 times since Dec 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.7303 per ML |
|---|---|
| All-time high | $5.8031 (Jan 14, 2026) |
| All-time low | $5.4876 (Apr 23, 2025) |
| 52-week high | $5.8031 |
| 52-week low | $5.6877 |
| Median price | $5.7414 |
| Average price | $5.7043 |
| Largest weekly change | +5.3% (Jul 23, 2025) |
| Weeks tracked | 94 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the orphenadrine citrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sagent Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
orphenadrine citrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Muscle Relaxant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ORPHENADRINE 60 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ORPHENADRINE 60 MG/2 ML VIAL, manufactured by Sagent Pharmaceuticals, is $5.7303 per ML (NDC 25021065102), effective Sep 30, 2026.
How has the price of ORPHENADRINE 60 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for ORPHENADRINE 60 MG/2 ML VIAL has held within roughly two percent of its current level. It has been tracked across 94 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for ORPHENADRINE 60 MG/2 ML VIAL?
Since Dec 18, 2024, the NADAC for ORPHENADRINE 60 MG/2 ML VIAL has ranged from a low of $5.4876 (Apr 23, 2025) to a high of $5.8031 (Jan 14, 2026), with a median of $5.7414 per ML.
Are there cheaper alternatives to ORPHENADRINE 60 MG/2 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of ORPHENADRINE 60 MG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ORPHENADRINE 60 MG/2 ML VIAL?
ORPHENADRINE 60 MG/2 ML VIAL (NDC 25021065102) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.